The Role of Depression, Anxiety, and Stress in Medication Adherence in Patients with Hypertension

Document Type : Original Article (s)

Authors

1 Associate Professor, Department of Community Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 MPH Student, Department of Community Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

3 Assistant Professor, Department of Medical Education, Medical Education Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

4 Researcher, Medical Education Development Center, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Despite the importance of psychological factors in adherence to the treatment in patients with hypertension, a few studies have been done to identify the factors affecting adherence to treatment and particularly to investigate the role of psychology factors in Iranian population. This study aimed to investigate the role of mental health in adherence to medication in patients with hypertension in rural areas of Isfahan Province, Iran.Methods: In this cross-sectional study, 300 patients with hypertension were studied. Multistage sampling was performed in health centers. Data collection tools included depression, anxiety and stress scale (DASS) short form and the Morisky 8-items medication adherence questionnaire. The odds ratio (OR) for different levels of depression, anxiety, and stress in both groups with appropriate adherence and non-appropriate adherence to treatment were determined. We used multivariate logistic regression model for statistical analysis.Findings: Patients with very severe levels of anxiety were more non-adherent to drug therapy than those with normal levels of anxiety (OR = 2.8; CI95%: 1.07-7.38). While other levels of anxiety and severity of depression and stress were not significant predictors for predicting patients' adherence to treatment.Conclusion: Understanding the severity of depression, stress, and anxiety to ensure adherence and treatment outcomes in patients with hypertension are essential. According to this study, very severe anxiety can be considered as an important predicting factor in the lack of adherence to medication.

Keywords

References

  1. Najimi A, Mostafavi F, Sharifirad G, Golshiri P. Patient's beliefs about adherence to medication toward hypertension: A qualitative study. International Journal of Advanced Biotechnology and Research 2016; 7 (Special Issue3): 1555-61.
  2. Mostafavi F, Najimi A, Sharifirad G, Golshiri P. Beliefs about medicines in patients with hypertension: The instrument validity and reliability in Iran. Mater Sociomed 2016; 28(4): 298-302.
  3. Thompson AM, Hu T, Eshelbrenner CL, Reynolds K, He J, Bazzano LA. Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a meta-analysis. JAMA 2011; 305(9): 913-22.
  4. Najimi A, Mostafavi F, Sharifirad G, Golshiri P. Barriers to adherence to pharmacotherapy among patients with hypertension: A cross-sectional study. Int J Med Res Health Sci 2016, 5(7S): 47-53.
  5. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr., et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report. JAMA 2003; 289(19): 2560-72.
  6. Shermock KM. Impact of continuity of care and provider factors on medication adherence in patients with hypertension. Ann Arbor, MI: The Johns Hopkins University; 2009.
  7. Wu JR, Moser DK, Chung ML, Lennie TA. Predictors of medication adherence using a multidimensional adherence model in patients with heart failure. J Card Fail 2008; 14(7): 603-14.
  8. Zygmunt A, Olfson M, Boyer CA, Mechanic D. Interventions to improve medication adherence in schizophrenia. Am J Psychiatry 2002; 159(10): 1653-64.
  9. Verbrugghe M, Verhaeghe S, Lauwaert K, Beeckman D, Van Hecke A. Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: a systematic review. Cancer Treat Rev 2013; 39(6): 610-21.
  10. Yiannakopoulou EC, Papadopulos JS, Cokkinos DV, Mountokalakis TD. Adherence to antihypertensive treatment: A critical factor for blood pressure control. Eur J Cardiovasc Prev Rehabil 2005; 12(3): 243-9.
  11. Bender BG, Rand C. Medication non-adherence and asthma treatment cost. Curr Opin Allergy Clin Immunol 2004; 4(3): 191-5.
  12. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160(14): 2101-7.
  13. Kretchy IA, Owusu-Daaku FT, Danquah SA. Mental health in hypertension: Assessing symptoms of anxiety, depression and stress on anti-hypertensive medication adherence. Int J Ment Health Syst 2014; 8: 25.
  14. Surilena, Ismail RI, Irwanto, Djoerban Z, Utomo B, Sabarinah, et al. The effect of rational emotive behavior therapy (REBT) on antiretroviral therapeutic adherence and mental health in women infected with HIV/AIDS. Acta Med Indones 2014; 46(4): 283-91.
  15. Crawford JR, Henry JD. The Depression Anxiety Stress Scales (DASS): Normative data and latent structure in a large non-clinical sample. Br J Clin Psychol 2003; 42(Pt 2): 111-31.
  16. Sahebi A, Asghari MJ, Salari R. Validation of Depression Anxiety and Stress Scale (DASS-21) for an Iranian population. J Iran Psychol 2005; 4: 299-313. [In Persian].
  17. Gordis L, Markowitz M, Lilienfeld AM. The inaccuracy in using interviews to estimate patient reliability in taking medications at home. Med Care 1969; 7(1): 49-54.
  18. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 2008; 10(5): 348-54.
  19. Beardon PH, McGilchrist MM, McKendrick AD, McDevitt DG, MacDonald TM. Primary non-compliance with prescribed medication in primary care. BMJ 1993; 307(6908): 846-8.
  20. Kerse N, Buetow S, Mainous AG, III, Young G, Coster G, Arroll B. Physician-patient relationship and medication compliance: a primary care investigation. Ann Fam Med 2004; 2(5): 455-61.
  21. DiMatteo MR. Variations in patients' adherence to medical recommendations: A quantitative review of 50 years of research. Med Care 2004; 42(3): 200-9.
  22. Shilling V, Jenkins V, Fallowfield L. Factors affecting patient and clinician satisfaction with the clinical consultation: Can communication skills training for clinicians improve satisfaction? Psychooncology 2003; 12(6): 599-611.
  23. Patel RP, Taylor SD. Factors affecting medication adherence in hypertensive patients. Ann Pharmacother 2002; 36(1): 40-5.
  24. Ogedegbe GO, Boutin-Foster C, Wells MT, Allegrante JP, Isen AM, Jobe JB, et al. A randomized controlled trial of positive-affect intervention and medication adherence in hypertensive African Americans. Arch Intern Med 2012; 172(4): 322-6.
  25. Hope CJ, Wu J, Tu W, Young J, Murray MD. Association of medication adherence, knowledge, and skills with emergency department visits by adults 50 years or older with congestive heart failure. Am J Health Syst Pharm 2004; 61(19): 2043-9.
  26. Krueger KP, Berger BA, Felkey B. Medication adherence and persistence: a comprehensive review. Adv Ther 2005; 22(4): 313-56.
  27. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, et al. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ 2004; 328(7440): 634-40.
  28. Krousel-Wood M, Joyce C, Holt E, Muntner P, Webber LS, Morisky DE, et al. Predictors of decline in medication adherence: Results from the cohort study of medication adherence among older adults. Hypertension 2011; 58(5): 804-10.
  29. Barnes S, Gott M, Payne S, Seamark D, Parker C, Gariballa S, et al. Communication in heart failure: perspectives from older people and primary care professionals. Health Soc Care Community 2006; 14(6): 482-90.
Journal of Isfahan Medical School
Volume 35, Issue 437 - Serial Number 437
May and June 2017
Pages 781-788

Files

History

  • Receive Date: 14 April 2017
  • Revise Date: 01 November 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics